image_alt_text
7

University of Minnesota Selected as National Hub by NIH to Accelerate New Inventions to the Market

Bin He | Via U. Minnesota | March 26, 2015

The University of Minnesota was recently selected by the National Institutes of Health (NIH) as one of three sites in the nation to establish a strategic Research and Evaluation Hub (REACH), helping to promote commercialization and technology transfer in life sciences and biomedicine. To develop the hub, NIH will invest $3 million grant with another $3 million in matching U of M funds. The university’s MIN-REACH program will provide commercial expertise and resources needed for the development and commercialization of diagnostics, therapeutics, preventive medicine and medical devices. The program will establish new industry partnerships, strengthen existing partnerships, and provide entrepreneurial, commercial-style education for innovators to accelerate the pace at which innovations reach the marketplace. It will fund between 10-20 research projects each year.

The University’s hub, MIN-REACH, will be led by Dr. Charles Muscoplat (PI), Professor of Food Science and Nutrition. Along with Dr. Muscoplat, multiple members of the Institute for Engineering in Medicine (IEM) are taking lead roles on the project. Dr. Allison Hubel (Co-PI), director of the IEM-affiliated Biopreservation Core Resource (BioCoR), and Professor of Mechanical Engineering, and Dr. Bin He (Co-PI), IEM director and Professor of Biomedical Engineering, will jointly lead the medical devices side of the program. Dr. Vadim Gurvich, Associate Professor of Pharmacy and associate director of the Institute for Therapeutics Discovery and Development, will co-lead, with Dr. Muscoplat, the pharmaceutical side of the program. In addition to the 4 Co-PIs, several IEM members are participating in the MN-REACH grant, including Dr. Kevin Peterson (Co-I), from the Department of Family and Community Health and director of the Center for Excellence in Primary Care, who will provide medical advice.

...